Cargando…
Histrelin Implants for Suppression of Puberty in Youth with Gender Dysphoria: A Comparison of 50 mcg/Day (Vantas) and 65 mcg/Day (SupprelinLA)
Purpose: Development of incongruent secondary sex characteristics in transgender youth can intensify or trigger the onset of gender dysphoria. Guidelines from professional organizations recommend gonadotropin-releasing hormone agonists, including histrelin implants (Vantas and SupprelinLA) to suppre...
Autores principales: | Olson-Kennedy, Johanna, Streeter, Laer H., Garofalo, Robert, Chan, Yee-Ming, Rosenthal, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906230/ https://www.ncbi.nlm.nih.gov/pubmed/33644320 http://dx.doi.org/10.1089/trgh.2020.0055 |
Ejemplares similares
-
Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology
por: Lello, Stefano, et al.
Publicado: (2014) -
Efficacy and safety of ultra-low-dose Vagifem (10 mcg)
por: Chollet, Janet A
Publicado: (2011) -
Co-registration of OPM-MCG signals with CT using optical scanning
por: Yang, Yanfei, et al.
Publicado: (2023) -
‘Walking epidural’: comparison of the analgesic efficacy of levobupivacaine 0.0625% + fentanyl 2mcg/mL versus ropivacaine 0.075% + fentanyl 2mcg/mL
por: Mingote, Álvaro, et al.
Publicado: (2023) -
Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2022)